ProCE Banner Series

Individualized Treatment Decisions for Your Patients in AML First Remission

Expert faculty will discuss the importance of treatment after first AML remission, review the latest data for a treatment option, and discuss shared decision making through a real patient story.

All Events

Individualized Treatment Decisions for Your Patients in AML First Remission

Past Events

October

29

2024

12:15 PM - 1:00 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Thomas William LeBlanc, MD, MA, MHS, FAAHPM, FASCO

Associate Professor of Medicine
Chief Patient Experience and Safety Officer for the Duke Cancer Institute
Director of Outcomes Research in Division of Hematologic Malignancies and Cellular Therapy
Duke University School of Medicine
Duke Cancer Institute
Durham, North Carolina